Literature DB >> 15293611

Clonal strains of Pseudomonas aeruginosa in paediatric and adult cystic fibrosis units.

M R O'Carroll1, M W Syrmis, C E Wainwright, R M Greer, P Mitchell, C Coulter, T P Sloots, M D Nissen, S C Bell.   

Abstract

Despite recent reports of clonal strains of Pseudomonas aeruginosa in cystic fibrosis (CF) units, the need for routine microbiological surveillance remains contentious. Sputum was collected prospectively from productive patients attending the regional paediatric and adult CF units in Brisbane, Australia. All P. aeruginosa isolates were typed using pulsed-field gel electrophoresis. Spirometry, anthropometrics, hospitalisations and antibiotic sensitivity data were recorded. The first 100 sputum samples (first 50 patients at each clinic) harboured 163 isolates of P. aeruginosa. A total of 39 patients shared a common strain (pulsotype 2), 20 patients shared a strain with at least one other patient and 41 patients harboured unique strains. Eight patients shared a strain identical to a previously reported Australian transmissible strain (pulsotype 1). Compared with the unique strain group, patients harbouring pulsotype 2 were younger and had poorer lung function. Treatment requirements were similar in these two groups, as were the rates of multiresistance. In conclusion, 59% of patients harboured a clonal strain, supporting the need for routine microbiological surveillance. In contrast to previously described clonal strains, the dominant pulsotype was indistinguishable from nonclonal strains with respect to both colonial morphology and multiresistance. The clinical significance of clonal strains remains uncertain and requires longitudinal study.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15293611     DOI: 10.1183/09031936.04.00122903

Source DB:  PubMed          Journal:  Eur Respir J        ISSN: 0903-1936            Impact factor:   16.671


  33 in total

Review 1.  Clinical significance of microbial infection and adaptation in cystic fibrosis.

Authors:  Alan R Hauser; Manu Jain; Maskit Bar-Meir; Susanna A McColley
Journal:  Clin Microbiol Rev       Date:  2011-01       Impact factor: 26.132

2.  Molecular epidemiological surveillance of multidrug-resistant Pseudomonas aeruginosa isolates in a pediatric population of patients with cystic fibrosis and determination of risk factors for infection with the Houston-1 strain.

Authors:  Ruth Ann Luna; Laura A Millecker; C Renee Webb; Sally K Mason; Elaine M Whaley; Jeffrey R Starke; Peter W Hiatt; James Versalovic
Journal:  J Clin Microbiol       Date:  2013-01-09       Impact factor: 5.948

3.  Pseudomonas aeruginosa in children with cystic fibrosis diagnosed through newborn screening: assessment of clinic exposures and microbial genotypes.

Authors:  Don Hayes; Susan E West; Michael J Rock; Zhanhai Li; Mark L Splaingard; Philip M Farrell
Journal:  Pediatr Pulmonol       Date:  2010-07

Review 4.  The changing microbial epidemiology in cystic fibrosis.

Authors:  John J Lipuma
Journal:  Clin Microbiol Rev       Date:  2010-04       Impact factor: 26.132

5.  Developing an international Pseudomonas aeruginosa reference panel.

Authors:  Anthony De Soyza; Amanda J Hall; Eshwar Mahenthiralingam; Pavel Drevinek; Wieslaw Kaca; Zuzanna Drulis-Kawa; Stoyanka R Stoitsova; Veronika Toth; Tom Coenye; James E A Zlosnik; Jane L Burns; Isabel Sá-Correia; Daniel De Vos; Jean-Paul Pirnay; Timothy J Kidd; David Reid; Jim Manos; Jens Klockgether; Lutz Wiehlmann; Burkhard Tümmler; Siobhán McClean; Craig Winstanley
Journal:  Microbiologyopen       Date:  2013-11-11       Impact factor: 3.139

6.  Comparison of three typing methods for Pseudomonas aeruginosa isolates from patients with cystic fibrosis.

Authors:  V Waters; J E A Zlosnik; Y C W Yau; D P Speert; S D Aaron; D S Guttman
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2012-07-29       Impact factor: 3.267

7.  A diagnostic PCR assay for the detection of an Australian epidemic strain of Pseudomonas aeruginosa.

Authors:  Heidi L Williams; Lynne Turnbull; Susan J Thomas; Anna Murphy; Tim Stinear; David S Armstrong; Cynthia B Whitchurch
Journal:  Ann Clin Microbiol Antimicrob       Date:  2010-07-16       Impact factor: 3.944

8.  Newly introduced genomic prophage islands are critical determinants of in vivo competitiveness in the Liverpool Epidemic Strain of Pseudomonas aeruginosa.

Authors:  Craig Winstanley; Morgan G I Langille; Joanne L Fothergill; Irena Kukavica-Ibrulj; Catherine Paradis-Bleau; François Sanschagrin; Nicholas R Thomson; Geoff L Winsor; Michael A Quail; Nicola Lennard; Alexandra Bignell; Louise Clarke; Kathy Seeger; David Saunders; David Harris; Julian Parkhill; Robert E W Hancock; Fiona S L Brinkman; Roger C Levesque
Journal:  Genome Res       Date:  2008-12-01       Impact factor: 9.043

9.  Pseudomonas aeruginosa population structure revisited.

Authors:  Jean-Paul Pirnay; Florence Bilocq; Bruno Pot; Pierre Cornelis; Martin Zizi; Johan Van Eldere; Pieter Deschaght; Mario Vaneechoutte; Serge Jennes; Tyrone Pitt; Daniel De Vos
Journal:  PLoS One       Date:  2009-11-13       Impact factor: 3.240

10.  Cough-generated aerosols of Pseudomonas aeruginosa and other Gram-negative bacteria from patients with cystic fibrosis.

Authors:  C E Wainwright; M W France; P O'Rourke; S Anuj; T J Kidd; M D Nissen; T P Sloots; C Coulter; Z Ristovski; M Hargreaves; B R Rose; C Harbour; S C Bell; K P Fennelly
Journal:  Thorax       Date:  2009-07-01       Impact factor: 9.139

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.